SCHEDULE 13G: Altium Capital Management Discloses 9.58% Stake in Femto Technologies Inc.

Altium Capital Management LLC and its affiliates have disclosed a 9.58% beneficial ownership stake in Femto Technologies Inc., primarily through common shares and pre-funded warrants.

Summary

• Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP, and Altium Healthcare Long Short GP LLC have jointly filed a Schedule 13G.
• They collectively beneficially own 479,616 common shares of Femto Technologies Inc.
• This represents 9.58% of Femto Technologies Inc.'s outstanding common stock.
• The ownership includes 279,616 shares of common stock and 200,000 shares issuable upon conversion of Pre-Funded Warrants.
• A "Warrant Blocker" prevents the reporting persons from exercising Pre-Funded Warrants if it would result in beneficial ownership exceeding 4.99% of outstanding common stock, though the reported amount does not give effect to this blocker.
• The filing explicitly states that 479,616 shares from Series A Warrants and 897,650 shares from Series B Warrants are not included in the reported beneficial ownership, and these are also subject to a 4.99% beneficial ownership limitation if they become registered and exercisable.
• The percentage of class is based on 2,920,067 common shares outstanding immediately after the offering, as communicated by the broker on March 6, 2025.
• The securities were not acquired for the purpose of changing or influencing control of Femto Technologies Inc.

Sentiment

Score: 6

Explanation: The disclosure of a significant stake by an institutional investor like Altium Capital Management is generally a positive signal, indicating confidence in the issuer. However, the presence of a 'Warrant Blocker' and unregistered warrants introduces some complexity and limitations on the investor's full potential ownership.

Positives

• A significant institutional investor, Altium Capital Management, has taken a substantial 9.58% stake in Femto Technologies Inc., potentially signaling confidence in the company's prospects.

Negatives

• No direct negatives are presented in this ownership disclosure.

Risks

• The "Warrant Blocker" limits the ability of Altium Capital Management and its affiliates to fully exercise their Pre-Funded Warrants if it would result in beneficial ownership exceeding 4.99% of outstanding common stock.
• Additional Series A Warrants (479,616 shares) and Series B Warrants (897,650 shares) are not yet registered and exercisable, and would also be subject to a 4.99% beneficial ownership limitation if they become so. This indicates potential future dilution or limitations on the investor's ability to increase their stake beyond the blocker.

Future Outlook

This Schedule 13G filing is an ownership disclosure and does not contain forward-looking statements or guidance regarding Femto Technologies Inc.'s future performance or outlook.

Industry Context

This filing indicates a significant investment by a healthcare-focused fund, Altium Capital Management, into Femto Technologies Inc. While the document does not provide specific industry trends, such an investment suggests that the investor sees potential within the healthcare technology or related sectors where Femto Technologies operates. It reflects a strategic move by Altium to gain a substantial, non-controlling stake in a company within its investment focus.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor taking a stake could be viewed positively, potentially increasing investor confidence and liquidity. The 'Warrant Blocker' and unregistered warrants might introduce future complexities regarding dilution or control dynamics.
• Company Management: The investment provides capital (if part of an offering) and a significant shareholder, but the filing explicitly states the stake is not for influencing control.

Next Steps

• The document does not explicitly mention future actions, events, or milestones for Femto Technologies Inc. or the reporting persons, beyond the potential future registration and exercise of Series A and B Warrants.

Key Dates

Recommendation

Keywords

Femto Technologies Inc., Altium Capital Management, Schedule 13G, Beneficial Ownership, Common Shares, Pre-Funded Warrants, Warrant Blocker, Institutional Investment, SEC Filing, Equity Stake